COLUMBIA, Md. and TORONTO, May 22,
2014 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and
TSXV: MFS) announced today that John
Mon, Chief Operating Officer will be a featured presenter at
the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
The Company's presentation by John
Mon, Chief Operating Officer is scheduled to begin at
2:30 p.m. ET.
The annual Marcum MicroCap Conference is a signature showcase
for superior quality, under-followed public companies with less
than $500 million in market
capitalization.
For more information or to register, please visit the conference
website at http://www.marcumllp.com/microcap or download the free
official conference app for the iPhone, iPad, or for Android mobile
devices in Apple's App Store and the Google Play Market.
About Medifocus, Inc.
Medifocus owns two fully developed technology platforms with
comprehensive United States and
international patent protection: (i) The Endo-thermotherapy
Platform-a catheter-basis focused heat technology platform that
utilizes natural body openings to deliver precise microwave
thermotherapy to the diseased sites. The United States Food and
Drugs Administration (FDA) approved Prolieve Thermodilatation
System for the treatment of Benign Prostatic Hyperplasia (BPH) was
developed based on the Endo-thermotherapy and is currently
generating revenue; and (ii) the Adaptive Phased Array (APA)
Microwave Focusing Platform, invented by the Massachusetts Institute of Technology, licensed to
Medifocus directs precisely focused microwave energy at tumor
center to induce shrinkage or eradication of tumors without undue
harm to surrounding tissue. Medifocus' APA 1000 Breast Cancer
Treatment System, developed from the APA technology platform, has
received approval from the FDA and Health Canada to conduct the
pivotal Phase III clinical trials. Medifocus believes that
these two technology platforms can provide the design basis for the
development of multiple cancer treatment systems for surface,
subsurface and deep seated localized and regional cancers.
Please visit www.medifocusinc.com, www.prolieve.com and
http://www.facebook.com/pages/Medifocus-Inc-Company-Page/546315028715627
for more details.
About Marcum LLP
Marcum LLP is one of the largest independent public accounting
and advisory services firms in the United
States. Ranked #15 nationally, Marcum LLP offers the
resources of 1,300 professionals, including over 160 partners, in
23 offices throughout the U.S., Grand
Cayman and China.
Headquartered in New York City,
the Firm's presence runs deep, with full-service offices
strategically located in major business markets. Marcum is a member
of the Marcum Group, an organization providing a comprehensive
range of professional services spanning accounting and advisory,
technology solutions, wealth management, and executive and
professional recruiting. The Marcum Group companies include Marcum
LLP; Marcum Technology LLC; Marcum Search LLC; Marcum Financial
Services LLC; Marcum Bernstein & Pinchuk LLP; MarcumBuchanan
Associates LLC; and Marcum Cronus Partners LLC. For more
information, visit www.marcumllp.com.
News Release
Corporate Contact: John Mon,
COO
Company Name: Medifocus Inc.
Contact Name: John Mon
Contact Phone: 410-290-5734
Company Email: info@medifocusinc.com
SOURCE Medifocus, Inc.